Immunological Medicines for Cattles
Immunological veterinary medicinal products, including vaccines, are authorised for cattle.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Zulvac BTV
|
Blauzungenkrankheit, Serotypen 1, 4 oder 8
|
Zoetis Belgium S.A., Belgien
|
EU/2/17/207/001-009 |
25.04.2017 |
Rind, Schaf |
EPAR: Zulvac BTV Ovis
|
BOVALTO Respi Intranasal
|
BRSV-Infektion, Parainfluenza-3
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.11947.01.1 |
19.03.2018 |
Rind |
PharmNet.Bund
|
UBAC
|
Mastitis
|
Laboratorios Hipra S.A.,Spanien
|
EU/2/18/227 |
26.07.2018 |
Rind |
EPAR: UBAC
|
SYVAZUL BTV
|
Blauzungenkrankheit, Serotypen 1, 4 oder 8
|
Laboratorios Syva, S.A.U., Spanien
|
EU/2/18/231/001-012 |
09.01.2019 |
Schaf, Rind |
EPAR: Syvazul BTV
|
Bovilis IntraNasal RSP Live
|
BRSV-Infektion, Bovine Parainfluenza
|
Intervet Deutschland GmbH
|
PEI.V.11976.01.1 |
18.05.2019 |
Rind |
PharmNet.Bund
|
NASYM
|
BRSV-Infektion
|
Laboratorios Hipra S.A., Spanien
|
EU/2/19/241 |
29.07.2019 |
Rind |
|
Bravoxin
|
Enterotoxämie, Rauschbrand, Pararauschbrand, Deutsche Bradsot, Gasödem, Tetanus, Infektiöse Hämoglobinurie
|
Intervet Deutschland GmbH
|
PEI.V.12037.01.1 |
03.08.2020 |
Rind, Schaf |
|
Rispoval 2 / BRSV + Pi3
|
BRSV-Infektion, Bovine Parainfluenza
|
Zoetis Deutschland GmbH
|
PEI.V.12018.01.1 |
18.11.2020 |
Rind |
|
Tricholor
|
Trichophytie
|
Ceva Tiergesundheit GmbH
|
PEI.V.12134.01.1 |
07.12.2021 |
Rind |
PharmNet.Bund
|
Fencovis
|
Rotavirus-Infektion, Corona-Infektion, E. coli-Infektion
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.12116.01.1 |
25.07.2022 |
Rind |
|
Bovilis Nasalgen-C
|
Coronavirus-Infektion
|
Intervet International B.V., Netherlands
|
EU/2/23/294 |
31.03.2023 |
Rind |
EPAR: Bovilis Nasalgen-C
|
Protivity
|
Mykoplasmen-Infektion
|
Zoetis Deutschland GmbH
|
PEI.V.12135.01.1 |
13.07.2023 |
Rind |
|
Bovilis Cryptium
|
Kryptosporidiose
|
Intervet International B.V., Netherlands
|
EU/2/23/303 |
24.11.2023 |
Rind |
EPAR: Bovilis Cryptium
|
DIVENCE PENTA
|
Bovine Virusdiarrhoe, Bovine Parainfluenza, Bovines Respiratorisches Synzytialvirus, Bovines Herpesvirus
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/24/307 |
10.04.2024 |
Rind |
EPAR: DIVENCE PENTA
|
DIVENCE TETRA
|
Bovine Virusdiarrhoe, Bovine Parainfluenza, Bovines Respiratorisches Synzytialvirus
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/24/310 |
10.05.2024 |
Rind |
EPAR: DIVENCE TETRA
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.